BridgeBio Pharma
BBIO
BBIO
213 hedge funds and large institutions have $2.53B invested in BridgeBio Pharma in 2023 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 76 increasing their positions, 58 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
213
Holders Change
+34
Holders Change %
+18.99%
% of All Funds
3.41%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.13%
New
59
Increased
76
Reduced
58
Closed
24
Calls
$53.7M
Puts
$52M
Net Calls
+$1.75M
Net Calls Change
+$435K
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
$85.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$4.75M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
$66M |
| 4 |
AIG
American International Group
New York
|
$44.8M |
| 5 |
BlackRock
New York
|
$151M |
